La evidencia del impacto de las tecnologías digitales más comúnmente usadas para apoyar la adherencia a la medicación de la TB

The Union 2017 - 48^th Union World Conference on Lung Health
11 - 14 October, 2017
Guadalajara, Mexico

Scientific Programme
11.10.2017

T - TB other
Workshop (WS)
08:00 – 11:00 Fray Alcalde

The evidence of impact from digital technologies most commonly used to support TB medication adherence
(La evidencia del impacto de las tecnologías digitales más comúnmente usadas para apoyar la adherencia a la medicación de la TB)

Chair / Coordinator: Dennis Falzon, Switzerland
Chair: Giovanni Battista Migliori, WHO
Coordinator: Kristian van Kalmthout, Netherlands

"Digital technologies present innovative approaches to strengthen TB efforts in patient care, surveillance, programme management and eLearning. The documented experience in their use for TB control and the evidence base for the effect of certain technologies are steadily increasing.

This workshop will focus on the state of the evidence for one specific aspect of TB care –support of medication adherence– and the sessions will include review of evidence, lessons learned from trials and programmatic application of the technologies along with a modelling of the potential impact. It will focus on three technologies in particular which are being used at large scale, namely: electronic medication monitors, short message service (mobile texting) and video (or virtual) supported care.

The workshop discussion fits into the ongoing work that is being facilitated by the WHO Global TB Programme, the European Respiratory Society (ERS) and the Global Task Force on digital health for TB. As a direct outcome of this workshop we envisage the production of a paper which will be submitted for publication to a major journal. This will complement other information and new policies on TB care to guide professionals, decision-makers, system developers and technical and funding agencies to make better choices when applying digital products in support of TB programmes."

• Translating evidence on TB medication adherence into action and into more questions
  Richard Lester, Canada
• What can we learn and do about TB treatment adherence through the use of medication packaging technology?
  Jessica Haberer, United States of America
• Modelling the costs and impacts of digital support for TB treatment
  Kevin Schwartzman, Canada
• Collecting data to assess the performance of video-supported TB therapy: useful lessons
  Richard S Garfein, United States of America
• World Health Organization perspectives on evidence and digital health support to the End TB Strategy
  Dennis Falzon, Switzerland